Renal Pelvis Cancer

• CLINICAL_TRIALS trial_result · 2026-07-21
  Clinical Trial Update: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study [Phase 3]

  Phase 3 ENLIGHTED study evaluating endoluminal light-activated treatment for transitional cell cancer of the renal pelvis and ureter has com…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]

  Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]

  A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer [Phase 3]

  Phase 3 trial evaluating adding tivozanib to pembrolizumab after surgery for kidney cancer; currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-03-24
  Clinical Trial Update: A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer [Phase 1, Phase 2]

  A study of Enfortumab Vedotin, alone or with other therapies, for urothelial cancers has been terminated.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-03-05
  Clinical Trial Update: Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery [EARLY_Phase 1]

  This early-phase trial update describes the combination of durvalumab and tremelimumab in cisplatin-ineligible muscle-invasive urothelial ca…

• CLINICAL_TRIALS research · 2025-08-22
  Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.

• CLINICAL_TRIALS trial_result · 2024-07-03
  Clinical Trial Update: Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma [Phase 2]

  Phase 2 trial results evaluate the combination of atezolizumab and CYT107 in participants with locally advanced, inoperable, or metastatic u…

• CLINICAL_TRIALS research · 2024-06-20
  Clinical Trial Update: Urine DNA Methylation Detection for Hematuria Evaluation

  ClinicalTrials.gov entry for a study evaluating urine DNA methylation as a noninvasive test to evaluate hematuria and screen for urothelial …

• CLINICAL_TRIALS trial_result · 2023-08-08
  Clinical Trial Update: Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study [Phase 2]

  Phase 2 trial evaluating gemcitabine to prevent intravesical recurrence of urothelial cancer in patients with upper tract urothelial cancer …

• CLINICAL_TRIALS trial_result · 2020-09-10
  Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]

  Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…

• CLINICAL_TRIALS trial_result · 2016-03-31
  Clinical Trial Update: Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies [Phase 1]

  A Phase 1 trial evaluating gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced solid tumors, including b…

• CLINICAL_TRIALS withdrawal · 2014-01-29
  Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]

  This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for …

• CLINICAL_TRIALS trial_result · 2011-08-04
  Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)

  This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…

• CLINICAL_TRIALS trial_result · 2011-01-07
  Clinical Trial Update: Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

  This clinical trial update evaluated whether gabapentin affects the risk of pancreatic and renal cancers; results were posted in 2011.